Insulet Return on Tangible Equity 2010-2025 | PODD
Current and historical return on tangible equity values for Insulet (PODD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Insulet Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.40B | $1.18B | 39.74% |
| 2024-12-31 | $0.42B | $1.06B | 47.77% |
| 2024-09-30 | $0.42B | $0.97B | 55.58% |
| 2024-06-30 | $0.40B | $0.85B | 62.71% |
| 2024-03-31 | $0.23B | $0.64B | 44.98% |
| 2023-12-31 | $0.21B | $0.58B | 45.98% |
| 2023-09-30 | $0.12B | $0.46B | 30.79% |
| 2023-06-30 | $0.06B | $0.40B | 17.67% |
| 2023-03-31 | $0.00B | $0.35B | 0.30% |
| 2022-12-31 | $0.00B | $0.35B | 1.50% |
| 2022-09-30 | $0.02B | $0.32B | 4.66% |
| 2022-06-30 | $0.04B | $0.32B | 8.99% |
| 2022-03-31 | $0.05B | $0.34B | 11.05% |
| 2021-09-30 | $-0.03B | $0.42B | -6.24% |
| 2021-06-30 | $-0.03B | $0.39B | -6.05% |
| 2020-12-31 | $0.01B | $0.54B | 1.75% |
| 2020-09-30 | $0.03B | $0.55B | 10.66% |
| 2020-06-30 | $0.02B | $0.51B | 11.23% |
| 2020-03-31 | $0.01B | $0.01B | 6.15% |
| 2019-12-31 | $0.01B | $0.02B | 8.98% |
| 2019-09-30 | $0.02B | $0.10B | 10.17% |
| 2019-06-30 | $0.02B | $0.20B | 9.99% |
| 2019-03-31 | $0.01B | $0.17B | 9.06% |
| 2018-12-31 | $0.00B | $0.16B | 2.10% |
| 2018-09-30 | $-0.01B | $0.15B | -10.69% |
| 2018-06-30 | $-0.02B | $0.13B | -17.82% |
| 2018-03-31 | $-0.02B | $0.13B | -32.88% |
| 2017-12-31 | $-0.03B | $0.11B | -57.45% |
| 2017-09-30 | $-0.03B | $0.03B | -122.11% |
| 2017-06-30 | $-0.03B | $0.02B | -133.33% |
| 2017-03-31 | $-0.03B | $0.02B | -189.09% |
| 2016-12-31 | $-0.03B | $0.02B | -589.47% |
| 2016-09-30 | $-0.05B | $0.03B | 2300.00% |
| 2016-06-30 | $-0.06B | $-0.01B | 800.00% |
| 2016-03-31 | $-0.07B | $-0.01B | -14600.00% |
| 2015-12-31 | $-0.07B | $-0.01B | -634.78% |
| 2015-09-30 | $-0.05B | $0.00B | -242.86% |
| 2015-06-30 | $-0.04B | $0.02B | -156.36% |
| 2015-03-31 | $-0.06B | $0.03B | -200.00% |
| 2014-12-31 | $-0.05B | $0.03B | -134.21% |
| 2014-09-30 | $-0.05B | $0.03B | -103.70% |
| 2014-06-30 | $-0.06B | $0.02B | -104.42% |
| 2014-03-31 | $-0.04B | $0.07B | -57.95% |
| 2013-12-31 | $-0.05B | $0.07B | -64.56% |
| 2013-09-30 | $-0.05B | $0.07B | -106.00% |
| 2013-06-30 | $-0.04B | $0.08B | -141.94% |
| 2013-03-31 | $-0.05B | $0.07B | -482.05% |
| 2012-12-31 | $-0.05B | $-0.02B | 784.62% |
| 2012-09-30 | $-0.06B | $-0.01B | -3666.67% |
| 2012-06-30 | $-0.06B | $0.00B | -518.18% |
| 2012-03-31 | $-0.05B | $0.01B | -245.78% |
| 2011-12-31 | $-0.05B | $0.02B | -133.33% |
| 2011-09-30 | $-0.05B | $0.03B | -112.77% |
| 2011-06-30 | $-0.05B | $0.04B | -104.62% |
| 2011-03-31 | $-0.06B | $0.06B | -111.76% |
| 2010-12-31 | $-0.06B | $0.07B | -131.89% |
| 2010-09-30 | $-0.06B | $0.03B | -123.76% |
| 2010-06-30 | $-0.06B | $0.04B | -165.99% |
| 2010-03-31 | $-0.07B | $0.04B | -268.00% |
| 2009-12-31 | $-0.07B | $0.06B | -394.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.252B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.138B | 26.52 |
| Boston Scientific (BSX) | United States | $158.236B | 37.74 |
| Stryker (SYK) | United States | $145.846B | 29.69 |
| EssilorLuxottica (ESLOY) | France | $137.406B | 0.00 |
| Medtronic (MDT) | Ireland | $114.967B | 16.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.252B | 0.00 |
| ResMed (RMD) | United States | $42.733B | 30.52 |
| Haleon (HLN) | United Kingdom | $42.722B | 24.39 |
| Agilent Technologies (A) | United States | $32.622B | 21.27 |
| GE HealthCare Technologies (GEHC) | United States | $32.252B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $25.729B | 17.02 |
| Terumo (TRUMY) | Japan | $25.658B | 33.33 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.281B | 11.74 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.485B | 0.00 |
| Baxter (BAX) | United States | $11.516B | 8.90 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.532B | 27.51 |
| Lantheus Holdings (LNTH) | United States | $4.944B | 12.47 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Prestige Consumer Healthcare (PBH) | United States | $3.667B | 16.38 |
| Haemonetics (HAE) | United States | $3.666B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.403B | 23.81 |
| ICU Medical (ICUI) | United States | $3.201B | 23.60 |
| LeMaitre Vascular (LMAT) | United States | $1.906B | 42.61 |
| AtriCure (ATRC) | United States | $1.807B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.630B | 11.21 |
| Green Thumb Industries (GTBIF) | United States | $1.543B | 34.71 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Curaleaf Holdings (CURLF) | Canada | $1.106B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.100B | 14.06 |
| Neogen (NEOG) | United States | $1.017B | 16.14 |
| BioLife Solutions (BLFS) | United States | $0.999B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.23 |
| Kestra Medical Technologies (KMTS) | United States | $0.795B | 0.00 |
| Valneva SE (VALN) | France | $0.638B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.612B | 0.00 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| CeriBell (CBLL) | United States | $0.550B | 0.00 |
| Owens & Minor (OMI) | United States | $0.533B | 4.42 |
| ZimVie (ZIMV) | United States | $0.529B | 20.40 |
| Surmodics (SRDX) | United States | $0.509B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.293B | 10.77 |
| Aurora Cannabis (ACB) | Canada | $0.260B | 77.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.240B | 20.23 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.226B | 6.35 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Brainsway (BWAY) | Israel | $0.221B | 58.60 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.18 |
| Vireo Growth (VREOF) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.159B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.144B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.09 |
| Safety Shot (SHOT) | United States | $0.116B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.105B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Zynex (ZYXI) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.80 |
| Nephros (NEPH) | United States | $0.034B | 46.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |